These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 17441731
21. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein. Labialle S, Dayan G, Gayet L, Rigal D, Gambrelle J, Baggetto LG. Nucleic Acids Res; 2004; 32(13):3864-76. PubMed ID: 15272088 [Abstract] [Full Text] [Related]
23. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B. Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489 [Abstract] [Full Text] [Related]
29. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms. Li X, Li JP, Yuan HY, Gao X, Qu XJ, Xu WF, Tang W. Methods Find Exp Clin Pharmacol; 2007 Nov 23; 29(9):607-17. PubMed ID: 18193112 [Abstract] [Full Text] [Related]
30. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Shi Z, Liang YJ, Chen ZS, Wang XH, Ding Y, Chen LM, Fu LW. Oncol Rep; 2007 Apr 23; 17(4):969-76. PubMed ID: 17342344 [Abstract] [Full Text] [Related]
31. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Yu ST, Chen TM, Tseng SY, Chen YH. Biochem Biophys Res Commun; 2007 Jun 22; 358(1):79-84. PubMed ID: 17482571 [Abstract] [Full Text] [Related]
32. Immunotoxin resistance in multidrug resistant cells. McGrath MS, Rosenblum MG, Philips MR, Scheinberg DA. Cancer Res; 2003 Jan 01; 63(1):72-9. PubMed ID: 12517780 [Abstract] [Full Text] [Related]
34. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells. Peng Z, Xiao Z, Wang Y, Liu P, Cai Y, Lu S, Feng W, Han ZC. Cancer Gene Ther; 2004 Nov 01; 11(11):707-12. PubMed ID: 15375375 [Abstract] [Full Text] [Related]
35. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid. Majumder S, Dutta P, Mukherjee P, Datta ER, Efferth T, Bhattacharya S, Choudhuri SK. Cancer Lett; 2006 Nov 28; 244(1):16-23. PubMed ID: 16410038 [Abstract] [Full Text] [Related]
37. Arsenic trioxide inhibits p-glycoprotein expression in multidrug-resistant human leukemia cells that overexpress the MDR1 gene. Wei H, Su H, Bai D, Zhao H, Ge J, Wang B, Yao X, Ma L. Chin Med J (Engl); 2003 Nov 28; 116(11):1644-8. PubMed ID: 14642128 [Abstract] [Full Text] [Related]
38. Multidrug resistance of acute leukemia and a strategy to overcome it. Motoji T, Motomura S, Wang YH. Int J Hematol; 2000 Dec 28; 72(4):418-24. PubMed ID: 11197207 [Abstract] [Full Text] [Related]
40. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. Bodey B, Taylor CR, Siegel SE, Kaiser HE. Anticancer Res; 1995 Dec 28; 15(6B):2461-8. PubMed ID: 8669809 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]